HealthQuill ANtivirals
Pfizer Inc., announced a $1.5 billion “multi-year” savings plan to cut costs of goods sold, on top of a similar $4 billion initiative unveiled in October last year, when sales of its Covid-19 vaccine plummeted.
Drugs Health Pharma

Pfizer Inc. unveils a new $1.5 billion plan to cut costs as vaccine sales fall

Pfizer Inc., announced a $1.5 billion “multi-year” savings plan to cut costs of goods sold, on top of a similar $4 billion initiative.

Read More
A recent spillover to mammals of H5N1 avian influenza needed to be “monitored closely” as the WHO readies vaccines and antivirals and urged governments to increase surveillance.
Climate Drugs Pharma

H5N1 influenza’s spread to mammals needs ‘close monitoring’

A recent spillover to mammals of H5N1 avian influenza needed to be “monitored closely” as the WHO readies vaccines and antivirals and urged.

Read More